Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

methylprednisolone sodium phosphate

Known as: medrol stabisol 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Methylprednisolone
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Adjunctive Oral Methylprednisolone in Pediatric Acute Pyelonephritis Alleviates Renal Scarring
OBJECTIVE: To determine if glucocorticoids can prevent renal scar formation after acute pyelonephritis in pediatric patients… Expand
Is this relevant?
2010
2010
Терапия тяжелых гестозов при недоношенной беременности
Objective: to improve pregnancy outcomes in severe gestosis. Subjects and methods: Sixty-five women with incomplete pregnancy in… Expand
Is this relevant?
1977
1977
The clinical pharmacology of methylprednisolone sodium phosphate. I. Intramuscular route of administration.
Intramuscularly administered methylprednisolone sodium phosphate (Medrol Stabisol) in single doses of 40, 80, or 160 mg… Expand
Is this relevant?
1977
1977
The clinical pharmacology of methylprednisolone sodium phosphate. II. Intravenous route of administration.
Doses of 1, 3, 5, 10, 20 and 30 mg/kg of methylprednisolone sodium phosphate (MSP) or methylprednisolone sodium succinate (MSS… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE